Abstract
Variation in clinical practice and its effect on outcome is little known for rare diseases such as primary antibody deficiency. As part of a national audit a survey of all 30 consultant immunologists in the United Kingdom dealing with primary antibody deficiency syndromes in adults and children was carried out in 1993 to ascertain their practices in diagnosis and management. Consensus guidelines were published after the survey was completed. Comparison of the survey results of clinical practice at the time the guidelines were published with the standards identified highlighted that the practice of a minority of specialists was at variance with their peers and with the consensus document, particularly in the use of intramuscular immunoglobulin, the dose and frequency of intravenous immunoglobulin, and target trough immunoglobulin G concentration, which has implications for the quality of patient care. However, much closer agreement existed in the key areas of management, such as diagnosis and selection of intravenous immunoglobulin. The approach and the problems identified are relevant to the management of other rare diseases, in which diagnosis and management is complex and there are few specialists with the necessary knowledge to undertake such care. This survey, the first attempted audit of practice, shows that within a motivated group of specialists highly significant differences in practice may exist and the authors emphasise the importance of setting clear guidelines against which care can be assessed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Björkander J., Bake B., Hanson L. A. Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Respir Dis. 1984 Oct;65(7):529–536. [PubMed] [Google Scholar]
- Blore J., Haeney M. R. Primary antibody deficiency and diagnostic delay. BMJ. 1989 Feb 25;298(6672):516–517. doi: 10.1136/bmj.298.6672.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chapel H. M. Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies. BMJ. 1994 Feb 26;308(6928):581–585. doi: 10.1136/bmj.308.6928.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chapel H., Brennan V., Delson E. Immunoglobulin replacement therapy by self-infusion at home. Clin Exp Immunol. 1988 Jul;73(1):160–162. [PMC free article] [PubMed] [Google Scholar]
- Knutsen A. P. Patients with Igg subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin. J Allergy Clin Immunol. 1989 Oct;84(4 Pt 2):640–647. doi: 10.1016/0091-6749(89)90203-0. [DOI] [PubMed] [Google Scholar]
- Liese J. G., Wintergerst U., Tympner K. D., Belohradsky B. H. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am J Dis Child. 1992 Mar;146(3):335–339. doi: 10.1001/archpedi.1992.02160150075025. [DOI] [PubMed] [Google Scholar]
- Roifman C. M., Levison H., Gelfand E. W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet. 1987 May 9;1(8541):1075–1077. doi: 10.1016/s0140-6736(87)90494-6. [DOI] [PubMed] [Google Scholar]
- Ryan A., Thomson B. J., Webster A. D. Home intravenous immunoglobulin therapy for patients with primary hypogammaglobulinaemia. Lancet. 1988 Oct 1;2(8614):793–793. doi: 10.1016/s0140-6736(88)92439-7. [DOI] [PubMed] [Google Scholar]
- Silk H. J., Ambrosino D., Geha R. S. Effect of intravenous gammaglobulin therapy in IgG2 deficient and IgG2 sufficient children with recurrent infections and poor response to immunization with Hemophilus influenzae type b capsular polysaccharide antigen. Ann Allergy. 1990 Jan;64(1):21–25. [PubMed] [Google Scholar]
- Sorensen R. U., Polmar S. H. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes. Am J Med. 1984 Mar 30;76(3A):83–90. doi: 10.1016/0002-9343(84)90325-5. [DOI] [PubMed] [Google Scholar]
- Spickett G. P., Misbah S. A., Chapel H. M. Primary antibody deficiency in adults. Lancet. 1991 Feb 2;337(8736):281–284. doi: 10.1016/0140-6736(91)90882-p. [DOI] [PubMed] [Google Scholar]